These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4306552)

  • 1. Comparative effects of tumor extracts on lymphocyte transformation in peripheral blood cultures of healthy persons and patients with breast cancer.
    Golob E; Fischer P; Holzner H; Kunze-Mühl E
    Z Krebsforsch; 1969; 72(2):155-61. PubMed ID: 4306552
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the tumor cell-lymphocyte interaction in patients with breast cancer.
    Deodhar SD; Crile G; Esselstyn CB
    Cancer; 1972 May; 29(5):1321-5. PubMed ID: 4336633
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoid cells in carcinoma of the breast. Failure of response to phytohaemagglutinin in vitro.
    Blomgren H; Glas U; Franzén S; Granberg PO
    Acta Radiol Ther Phys Biol; 1973 Oct; 12(5):434-42. PubMed ID: 4360142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphoid cells in the venous blood of 100 female patients with breast carcinoma. Follow-up studies].
    Lellé RJ; Heidenreich W; Peter HH
    Onkologie; 1985 Aug; 8(4):241-5. PubMed ID: 3005936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of breast presenting as gastric cancer: diagnosis by immunoperoxidase staining patterns.
    Finch PJ; Rogers K; Holt S
    J R Coll Surg Edinb; 1989 Aug; 34(4):225-6. PubMed ID: 2553937
    [No Abstract]   [Full Text] [Related]  

  • 6. The lymphocyte locomotion assay in colon and breast cancer long survivors.
    Fazio M; Calabrese F; Giacomasso S; Negri L; Mastromatteo V
    Panminerva Med; 1993 Mar; 35(1):16-21. PubMed ID: 8391132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic response and prognosis in patients with breast cancer. II. Prognostic value of morphological and functional indicators of cellular response].
    Smolak K
    Nowotwory; 1984; 34(1):21-30. PubMed ID: 6330700
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
    Hellström I; Hellström KE; Sjögren HO; Warner GA
    Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of a protease from the cell-free medium of in vitro cultured mammary carcinoma.
    Hakim AA
    Experientia; 1976 Aug; 32(8):1057-9. PubMed ID: 182524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA positivity in sera and breast tumor tissues obtained from the same patients.
    von Kleist S; Wittekind C; Sandritter W; Gropp H
    Pathol Res Pract; 1982; 173(4):390-401. PubMed ID: 6289290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph nodes and serum immunoglobulins in breast cancer.
    Lee YT; Richters A
    J Am Med Womens Assoc (1972); 1977 Dec; 32(12):455-6, 461-6. PubMed ID: 201690
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoreticular malignancies and immunologic abnormalities in a sibship.
    Potolsky AI; Heath CW; Buckley CE; Rowlands DT
    Am J Med; 1971 Jan; 50(1):42-8. PubMed ID: 4321840
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinoma.
    Tanaka H; Shimoda T; Uchida K; Suzuki T; Ishikawa E
    Acta Pathol Jpn; 1986 Oct; 36(10):1455-68. PubMed ID: 3026138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
    Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
    Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local cellular and tributary lymphocyte immunity in cancer of the breast. Diagnostic and prognostic evaluations].
    Boscaino N; De Falco A
    Arch Sci Med (Torino); 1978; 135(2):209-18. PubMed ID: 210742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between sIgM positive lymph-node lymphocytes and breast cancer metastasis.
    Richters A; Paller M
    J Surg Oncol; 1979; 11(1):79-84. PubMed ID: 219301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer with late recurrence. A preliminary report].
    Hartveit F; Wiig J
    Nord Med; 1971 Jun; 85(24):748-50. PubMed ID: 4326356
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Considerations on cancer of the male breast based on 9 cases].
    Tagliacozzo S; Thau A
    Policlinico Chir; 1966 Oct; 73(5):319-41. PubMed ID: 4297688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.